We are looking for a highly motivated postdoctoral scholar at Stanford University School of Medicine. The major focus of the NIH-funded lab is to develop novel diagnostic, prognostic, and predictive biomarkers for precision cancer medicine. Through close collaboration with clinicians at Stanford and beyond, we have access to unique, high-quality, well-annotated clinical specimens to support our biomarker research. Our lab is generously funded by 3 active NIH R01 grants. Our work has been published in top clinical journals such as JAMA Oncology, Clinical Cancer Research, Radiology, etc. Please visit http://med.stanford.edu/lilab
The project involves discovery and development of DNA methylation biomarkers for liquid biopsy-based early cancer detection and prognostication. Candidates from a diverse background are encouraged to apply. The applicant may hold a PhD either in physical sciences or engineering with a strong motivation to solve biomedical problems, or in biomedical sciences with a strong interest to apply computational approaches. The ideal candidates will have strong statistical, machine learning, and programming skills. Prior research experience in cancer genomics, transcriptomics, or epigenetics is preferred.
I am strongly dedicated to cultivating and mentoring the next generation scientists in biomedical research. Postdocs and students in the lab have gone on to establish their own independent labs in academia or secure jobs in healthcare or technology industry. Major awards to my postdoc trainees include ASTRO Resident Clinical/Basic Science Research Award, ASTRO Basic/Translational Science Award. ASTRO is the world’s largest professional society for radiation oncologists. One of my trainees recently received the prestigious NIH K99/R00 Pathway to Independence Award from the NCI, which provides $1,000,000 over 5 years to establish an independent research program with a tenure-track faculty position in the US.
Stanford University is located at the heart of Silicon Valley, epicenter of the technology revolution in biomedicine. This is an excellent opportunity not only for those motivated to pursue an academic career, but also for those interested in entrepreneurship with the goal of commercialization and translation of new technology into clinical practice.
Interested applicants should send a research statement, CV, and names of three references to:
Ruijiang Li, PhD DABR